针对IDH1突变驱动的Nrf2信号,以抑制纤维瘤细胞中的恶性行为
Seoyeon Park1, Kyung-Soo Chun2, Do-Hee Kim1
1Department of Chemistry, Kyonggi University, Suwon, 16227 Republic of Korea.
Toxicological research
|April 28, 2025
概括
异酸脱酶1 (IDH1) 突变会损害抗氧化途径并促进癌症的进展. 准IDH1-Nrf2轴可能通过调节免疫反应和细胞迁移来为IDH1-突变癌症提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 异酸脱酶1 (IDH1) 突变在癌症中很常见,影响细胞代谢和氧化还原平衡.
- IDH1突变导致尼古丁胺胺氨基二核酸盐 (NADPH) 减少和谷氨合成受损.
- 核因子2 (Nrf2) 是抗氧化反应的关键调节者.
研究的目的:
- 研究IDH1突变在调节纤维瘤中Nrf2介导信号通路中的作用.
- 探索IDH1抑制对癌细胞行为和免疫规避的影响.
主要方法:
- 在HT1080纤维瘤细胞中利用siRNA击败IDH1.
- 评估了Nrf2稳定,抗氧化基因表达,活性氧物种 (ROS) 生产和细胞迁移.
- 使用小分子抑制剂向IDH1 R132突变.
- 分析了编程死亡配体1 (PD-L1) 的表达.
主要成果:
- 通过IDH1倒置抑制了Nrf2稳定,并减少了抗氧化基因表达,有利于癌症的进展.
- 抑制IDH1降低了ROS的产生,并损害了细胞迁移和殖民地形成.
- 针对IDH1 R132突变抑制了细胞迁移和殖民地形成.
- IDH1和Nrf2调节PD-L1的表达,有助于免疫逃避.
结论:
- IDH1突变在调节Nrf2介导的抗氧化防御和促进恶性表型方面发挥着至关重要的作用.
- 针对IDH1-Nrf2轴为IDH1-突变癌症提供了一个潜在的治疗策略.
- 这个轴通过PD-L1调制影响免疫逃避,为免疫疗法开发提供了洞察力.
更多相关视频
相关概念视频
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K


